Adhesion Barriers Market worth 1,216.8 M USD by 2021

Friday 19 August 2016, Amsterdam

The report, now available on ASDReports, "Adhesion Barrier Market by Product (Hyaluronic Acid, Fibrin, Regenerated Cellulose, Collagen & Protein), Product Form (Film, Gel, Liquid), Application (General, Orthopedic, Reconstructive, Neurological, & Gynecological Surgeries) - Global Forecast to 2021", analyses and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

This report studies the global adhesion barriers market during the forecast period of 2016 to 2021. This market is expected to grow at a CAGR of 8.4% during the forecast period, to reach USD 1,216.8 Million by 2021. Growth in this market is attributed to factors such as increasing number of surgeries, rising geriatric population, and growth in the number of sports-related and hand & wrist injuries. However, factors such as limited technological developments due to stringent regulations may restrain the growth of this market to a certain extent.

The global adhesion barriers market is segmented by product type, product form, application, and geography. On the basis of product type, the market is segmented into natural adhesion barriers and synthetic adhesion barriers. Synthetic adhesion barriers include hyaluronic acid, regenerated cellulose, polyethylene glycol (PEG), and other synthetic adhesion barriers; whereas, natural adhesion barriers include collagen & proteins and fibrin-based products. On the basis of product form, the market is segmented into film formulations, gel formulations, and liquid formulations. Based on applications, the market is segmented into neurological surgeries, cardiovascular surgeries, general surgeries, orthopedic surgeries, thoracic surgeries, gynecological surgeries, urological surgeries, reconstructive surgeries, and other surgeries.

In 2015, the synthetic adhesion barriers segment accounted for the largest share of the global adhesion barriers market. This is majorly attributed to the widespread use of products such as hyaluronic acid and regenerated cellulose in surgeries. Moreover, rising incidence of cardiovascular diseases, neurological diseases, and other related diseases is further expected to drive the demand for synthetic adhesion barriers during the forecast period.

In this report, the adhesion barriers market is broadly segmented into five major regions North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Presence of leading market players, coupled with the presence of a well-developed healthcare system, is the major factor responsible for the large share of North America in this market. However, the Asia-Pacific region is expected to grow at the highest CAGR, owing to increasing awareness about adhesion barriers, improvements in the region’s healthcare infrastructure, and rising disposable incomes.

Some of the major players operating in the global adhesion barriers market include Baxter International Inc. (U.S.), Medtronic Plc. (U.S.), C. R. Bard, Inc. (U.S.), Johnson & Johnson (U.S.), Sanofi Group (France), Atrium Medical Corporation (U.S.), Integra Lifesciences Corporation (U.S.), Anika Therapeutics Inc. (U.S.), FzioMed, Inc. (U.S.), and MAST Biosurgery AG (Switzerland).